Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.R500017200 on October 21, 2005

J. Biol. Chem., Vol. 281, Issue 2, 677-680, January 13, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/2/677    most recent
R500017200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garrett, S. C.
Right arrow Articles by Bresnick, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garrett, S. C.
Right arrow Articles by Bresnick, A. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Minireview

S100A4, a Mediator of Metastasis*

Sarah C. Garrett§, Kristen M. Varney{ddagger}, David J. Weber{ddagger}1, and Anne R. Bresnick§2

From the §Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461 and the {ddagger}Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201


   INTRODUCTION
TOP
 INTRODUCTION
S100 Protein Family
 S100A4 Discovery, Expression,...
 Gene Structure and Regulation
 Intracellular Roles and Targets
 Extracellular Roles and Targets
 Perspectives
 REFERENCES
 
The transition from benign tumor growth to malignancy is manifested by the ability of tumor cells to traverse tissue barriers and invade surrounding tissues. The traversal of basement membrane barriers is thought to be the critical event in the initiation of the metastatic cascade and, as described by the three-step hypothesis of metastasis, involves attachment to the extracellular matrix, local proteolysis, and subsequent migration (1). In recent years, a number of specific genes have been identified, the expressions of which correlate with tumorigenesis and/or metastatic potential. S100A4 is a member of the S100 family of calcium-binding proteins that is directly involved in tumor metastasis. This report reviews the animal and cellular studies implicating S100A4 in the establishment of the metastatic phenotype and examines the biochemical properties of S100A4 that are relevant to its role as a metastasis factor.


   S100 Protein Family
TOP
 INTRODUCTION
 S100 Protein Family
S100A4 Discovery, Expression,...
 Gene Structure and Regulation
 Intracellular Roles and Targets
 Extracellular Roles and Targets
 Perspectives
 REFERENCES
 
In humans there are now over 20 S100 family members that are distributed tissue specifically (2–4). The first family members were discovered in the brain by Moore (5) and given the name S100 because they are soluble in 100% saturated ammonium sulfate (5). As for most S100 family members, S100A4 is a symmetric homodimer stabilized by noncovalent interactions between two helices from each subunit (helices 1, 4, 1',4') that form an X-type four-helix bundle (Fig. 1). Each S100A4 subunit has two EF-hand Ca2+-binding domains: a pseudo-EF-hand or S100-hand and a typical EF-hand (CaKD = 2.6 µM) (6), which are brought into close proximity by a small two-stranded antiparallel beta-sheet (7). The pseudo-EF-hand differs from prototypical EF-hands because it is composed of 14 residues (rather than 12) and coordinates calcium weakly via backbone carbonyl oxygen atoms rather than with side chain oxygen atoms of Asp, Glu, Asn, or Gln (8–10). For S100A4, the pseudo-EF-hand is formed by helices 1 and 2 and is similar in conformation to other members of the S100 family. The orientation of helices 3 and 4 in the S100A4 typical EF-hand is similar to only one other member of the S100 protein family, S100A6 (11), and less like other S100 family members for which three-dimensional structures are available in the calcium-free state (12, 13). The difference in the position of helix 3 in the apo-state of these S100 proteins is due to variations in the amino acid sequence in the C terminus of helix 4 and in loop 2 (the hinge region) and is used to subclassify the S100 protein family (7). For S100A4, there is a C-terminal loop following helix 4 that is quite long and very basic, which makes it particularly unique when compared with other S100 proteins. In general, the "hinge region" and the C-terminal loop of S100 proteins are involved in target protein binding; therefore, the lack of sequence homology in these regions provides a means for S100 proteins to interact with specific binding partners (14). S100A4 and most other dimeric S100 proteins undergo a relatively large conformational change in the typical EF-hand upon binding calcium, which exposes a hydrophobic binding pocket comprising residues in helices 3 and 4, the hinge region, and the C-terminal loop. This calcium-dependent conformational change is necessary for S100A4 to interact with its protein targets and generate a biological effect (11, 15–18). Similar to other S100 proteins (19), target binding significantly enhances the calcium binding affinity (KD ~ 0.2 µM) of S100A4 (6). This provides a mechanism for the formation of a high affinity complex in vivo that occurs only when calcium, S100A4, and one of its target proteins are present (Fig. 1).


   S100A4 Discovery, Expression, and the Metastatic Phenotype
TOP
 INTRODUCTION
 S100 Protein Family
 S100A4 Discovery, Expression,...
Gene Structure and Regulation
 Intracellular Roles and Targets
 Extracellular Roles and Targets
 Perspectives
 REFERENCES
 
The S100A4 gene was cloned independently by several groups under various names, including metastasin (Mts1), fibroblast-specific protein (FSP1), 18A2, pEL98, p9Ka, 42A, CAPL, and calvasculin (20–27). Initial cloning efforts identified S100A4 as a highly expressed transcript in growth-stimulated cultured cells (23, 28) and metastatic tumor cell lines (20) and during morphogenic conversion from an epithelial to mesenchymal phenotype (21). In addition, S100A4 expression levels are up-regulated during oncogenic transformation (29, 30). Northern blot analyses indicate that S100A4 is expressed in several adult mouse and rat tissues, with high expression found in the spleen, thymus, bone marrow, T-lymphocytes, neutrophils, and macrophages (31, 32). Immunohistochemical analysis of rat tissues shows that S100A4 is expressed in some absorptive and keratinized epithelia, in the parietal cells of the stomach, and in a subset of cells of the immune system in the blood, bone marrow, spleen, and lymph nodes (33). Similar studies examining S100A4 expression during mouse development demonstrate that S100A4 is highly expressed in embryonic macrophages, as well as in differentiating mesenchymal tissues (34). S100A4 expression is also observed in metastatic cancers. Immunohistochemical analyses of human cancers shows significant S100A4 expression in breast, pancreatic, prostate, gallbladder, esophageal, gastric, lung, and thyroid carcinomas (35–42). In these cancers S100A4 expression is found at elevated levels compared with normal tissue, suggesting that enhanced S100A4 expression contributes to manifestation of a metastatic phenotype.

Studies in rodents have provided evidence supporting the direct involvement of S100A4 in tumor progression and metastasis. The role of S100A4 in cancer has been examined most widely in breast cancer models, which have demonstrated that overexpression of S100A4 in nonmetastatic mammary tumor cells confers a metastatic phenotype (43, 44). Transgenic mice that overexpress S100A4 in the mammary epithelium are phenotypically indistinguishable from wild-type mice (45), demonstrating that S100A4 itself is not tumorigenic; however, transgenic mouse models of breast cancer have shown that S100A4 expression correlates with metastasis. MMTV-neu and GRS/A animals are characterized by a high incidence of mammary tumors that rarely metastasize; overexpression of S100A4 in the mammary epithelium of these animals causes more invasive primary tumors and the appearance of metastases in the lungs (45, 46). The link between S100A4 and metastasis is further supported by knockdown experiments, as inhibition of S100A4 expression by antisense or anti-ribozyme techniques suppresses the metastatic capacity of S100A4-expressing tumor cells in animal models of lung carcinoma and osteosarcoma (47, 48). In addition, recent studies demonstrate that when transgenic mice expressing the polyoma virus middle T antigen are crossed with mice carrying null alleles for S100A4, they display a significant decrease in lung metastases (49). Altogether these observations suggest that S100A4 is not simply a marker for metastatic disease but rather has a causal role in mediating this process.

The association between S100A4 expression and metastasis observed in animal studies has led to a number of studies examining the utility of S100A4 expression as a prognostic marker in human cancers. In a retrospective study of 349 invasive human breast cancer specimens, S100A4 expression and other variables were evaluated for their prognostic significance over a period of 14–20 years (50, 51). Analysis of patients with carcinomas that stain positively for S100A4 expression demonstrated that S100A4 expression is highly correlated with patient death. In addition to breast cancer, S100A4 has been shown to be a prognostic marker in a number of human cancers, including esophageal-squamous cancers (39), non-small lung cancers (41), primary gastric cancers (40), malignant melanomas (52), prostate cancers (37, 53), bladder cancers (54), and pancreatic carcinomas (36, 55). The universality of S100A4 expression in a variety of cancers illustrates the potential use of S100A4 as a marker for tumor metastasis and disease progression.


   Gene Structure and Regulation
TOP
 INTRODUCTION
 S100 Protein Family
 S100A4 Discovery, Expression,...
 Gene Structure and Regulation
Intracellular Roles and Targets
 Extracellular Roles and Targets
 Perspectives
 REFERENCES
 
The majority of the human, mouse, and rat S100 genes, including S100A4, are located as a gene cluster on chromosomes 1q21, 3f3, and 2q34, respectively (56). The mouse S100A4 gene consists of three exons and two introns (57). The first exon is noncoding and contains the 5'-UTR3 of the gene, the second exon contains the start codon and encodes the N-terminal EF-hand, and the third exon encodes the C-terminal EF-hand. The human S100A4 gene contains 4 exons, and the additional exon is located within the 5'-UTR and is noncoding. In addition, there are two variants of the human S100A4 as a result of alternative splicing within the 5'-UTR (58). The two splice variants display different expression profiles in human tissues and tumor cell lines (57); however, the significance of this observation with respect to gene or protein activity is not known. The S100A4 promoter contains an ErbB2 response element (59), and transcription of the S100A4 gene is controlled by both positive and negative regulatory elements located within the first intron, which bind several transcription factors (60–63). Furthermore, hypermethylation of the S100A4 gene is associated with transcriptional silencing (64–66).


Figure 1
View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 1.
The calcium-dependent interaction of S100A4 with protein targets. Ribbon diagrams of the NMR solution structure of apo-S100A4 (left) and a homology model of calcium-bound S100A4 (right) illustrating the movement of helix 3 (shown in orange) upon the addition of calcium (red spheres) as described by Vallely et al. (7) are shown. This conformational change is required for S100A4 binding to protein targets such as myosin IIA, p53, and annexin II.

 
Genetic deletion of S100A4 (S100A4–/– mice) has no overt phenotype in the postnatal period but results in a low incidence of spontaneous tumors late in life. The gender ratio of the knock-out mice is affected also, with fewer –/– females being born than –/– males (67). In addition, recent studies show that following orthotopic injection of a highly metastatic, S100A4-positive, carcinoma cell line into S100A4–/– mice, tumor development and the formation metastases are suppressed (68). These observations suggest that S100A4 expression in host-derived stroma may also contribute to tumor progression and metastasis.


   Intracellular Roles and Targets
TOP
 INTRODUCTION
 S100 Protein Family
 S100A4 Discovery, Expression,...
 Gene Structure and Regulation
 Intracellular Roles and Targets
Extracellular Roles and Targets
 Perspectives
 REFERENCES
 
Several proteins have been identified as S100A4 targets, including liprin beta1 (69), methionine aminopeptidase (70), the p53 tumor suppressor protein (71), and proteins involved in cytoskeletal rearrangement and cell motility such as F-actin, tropomyosin, and the heavy chain of nonmuscle myosin II (72–74). In all of these cases, the interaction of these protein targets with S100A4 is calcium-dependent and thus links the cellular functions of these proteins to changes in the intracellular calcium concentration (Fig. 1). It has been a general observation that two-hybrid screens utilizing S100 proteins as bait have detected primarily other S100 family members as targets (75–78). Heterodimerization is not calcium-dependent, as was confirmed in vitro for several S100 pairs (13, 76), and likely results from the low dissociation constant for dimerization (≤picomolar) for the S100 proteins (79). The S100A1-S100A4 complex, which was identified using two-hybrid screening methods (75, 76), is not readily detected with in vitro mixtures of S100A4 and S100A1 (75) casting some doubt about the relevance of this interaction in vivo.

Several S100 proteins, including S100A4, regulate the p53 tumor suppressor protein. Similar to S100B, S100A4 interacts with the C terminus of p53 and inhibits protein kinase C (PKC) phosphorylation of the tumor suppressor in vitro (71, 80, 81). Likewise, the interaction between p53 and either S100B or S100A4 inhibits p53 from binding to its consensus DNA-binding sequence (71, 82); thus it was expected that S100A4 would be a general inhibitor of p53 function. However, an examination of p53-regulated genes in S100A4-expressing cells indicates that the expression of several genes are up-regulated (e.g. bax); others genes are down-regulated initially and then later up-regulated (e.g. mdm2), and some genes are inhibited (e.g. p21, thrombospondin-1) (71). Several of these p53-responsive genes are pro-survival, whereas others are pro-apoptotic. These seemingly opposite effects of S100A4 expression on p53-regulated genes could result from differences in the cell lines used in the various studies. Notwithstanding the potential interaction between S100A4 and p53, S100A4 expression consistently promotes the acquisition of an invasive phenotype. This is likely not due to the interactions of S100A4 with p53 but is likely the consequence of direct interactions with other targets such as cytoskeletal proteins.

S100A4 selectively binds to the A isoform of nonmuscle myosin II (myosin IIA) and promotes the monomeric, unassembled state (83, 84). The S100A4 binding site maps to residues 1909–1924 in the C-terminal end of the coiled-coil of the myosin IIA heavy chain (84, 85). Recent studies demonstrate that although the S100A4 binding site overlaps a PKC phosphorylation site at Ser-1917, S100A4 binding is not affected by PKC phosphorylation. However, phosphorylation on the CK2 site at Ser-1944, which is located downstream of the S100A4 binding site in the tail piece, inhibits S100A4 binding (86). Moreover, CK2 phosphorylation protects against S100A4-induced inhibition of filament assembly and S100A4-induced disassembly of myosin IIA filaments. These findings demonstrate that heavy chain phosphorylation at the CK2 site provides, in addition to calcium binding, another regulatory mechanism for the S100A4-myosin IIA interaction. With respect to its effects on cell locomotion, S100A4 modulates cellular motility by effecting the orientation and localization of cellular protrusions. S100A4-expressing cells display few side protrusions and extensive forward protrusions during chemotaxis as compared with cells that do not express S100A4.4 Moreover, these effects are due to the specific interaction of S100A4 with myosin IIA. Altogether, these data suggest that S100A4 may modulate the metastatic phenotype through the regulation of cellular motility and myosin IIA function.


   Extracellular Roles and Targets
TOP
 INTRODUCTION
 S100 Protein Family
 S100A4 Discovery, Expression,...
 Gene Structure and Regulation
 Intracellular Roles and Targets
 Extracellular Roles and Targets
Perspectives
 REFERENCES
 
There is accumulating evidence that S100 proteins have extracellular functions; however, their mechanism of secretion remains unknown. S100A4 is secreted constitutively by fibroblasts in culture, and co-culture of tumor cells and fibroblasts stimulates the release of S100A4 by fibroblasts (27, 87). In addition, in S100A4 transgenic mice, S100A4 accumulates in the blood of aging animals (88). Extracellular S100A4 stimulates MMP-13 activity and acts as a moderate prometastatic factor of tumor cells (87). In osteosarcoma cells, inhibition of S100A4 mRNA expression significantly reduces MMP-2, MT1-MMP, and TIMP-1 mRNA expression (89), and oncogenic transformation of Madin-Darby canine kidney cells increases MT1-MMP and S100A4 expression (90), suggesting that the coordinated action of S100A4 and matrix metalloproteinases contributes to the invasive phenotype. Recently, S100A4 has been shown to bind annexin II, an endothelial plasminogen co-receptor. This interaction accelerates plasminogen activation by tissue plasminogen activator on the endothelial cell surface to generate plasmin, which is known to activate pro-MMPs (91). Thus S100A4 may also promote metastasis by inducing remodeling of the extracellular matrix and as a result facilitate angiogenesis and tumor invasion.


   Perspectives
TOP
 INTRODUCTION
 S100 Protein Family
 S100A4 Discovery, Expression,...
 Gene Structure and Regulation
 Intracellular Roles and Targets
 Extracellular Roles and Targets
 Perspectives
REFERENCES
 
Although S100A4 is established as a regulator of metastasis, the mechanisms by which it promotes an invasive phenotype are not well understood. Biochemical and cell-based studies point to the involvement of S100A4 in at least two steps in the metastatic cascade: remodeling of the extracellular matrix and cellular motility. However, the details of how S100A4 regulates its protein targets and how these interactions influence cellular functions remains to be determined. Identification and characterization of the molecular mechanisms by which S100A4 regulates its effectors will provide the biochemical foundation for understanding the contribution of S100A4 to normal and metastatic processes and will provide important new insights into the molecular basis for the invasive behavior of tumor cells. This mechanistic information can be applied to the use of S100A4 as a diagnostic marker and as a target for novel therapies.


   FOOTNOTES
 
* This minireview will be reprinted in the 2006 Minireview Compendium, which will be available in January, 2007. This work was supported by National Institutes of Health Grants GM069945 (to A. R. B.) and GM58888 (to D. J. W.) and American Cancer Society Grant CDD-107745 (to D. J. W.). Back

1 To whom correspondence may be addressed: Dept. of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene St., Baltimore, MD 21201. Tel.: 410-706-4354; Fax: 410-706-0458; E-mail: dweber{at}umaryland.edu. 2To whom correspondence may be addressed: Dept. of Biochemistry, AECOM, 1300 Morris Park Ave., Bronx, NY 10461. Tel.: 718-430-2741; Fax: 718-430-8565, E-mail: bresnick{at}aecom.yu.edu.

3 The abbreviations used are: UTR, untranslated region; PKC, protein kinase C; MMP, matrix metalloproteinase. Back

4 Z.-H. Li and A. R. Bresnick, unpublished observations. Back


   ACKNOWLEDGMENTS
 
We thank Steven Almo for helpful discussions.



   REFERENCES
TOP
 INTRODUCTION
 S100 Protein Family
 S100A4 Discovery, Expression,...
 Gene Structure and Regulation
 Intracellular Roles and Targets
 Extracellular Roles and Targets
 Perspectives
 REFERENCES
 

  1. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L. A. (1993) Annu. Rev. Cell Biol. 9, 541–573[CrossRef][Medline] [Order article via Infotrieve]
  2. Zimmer, D. B., Cornwall, E. H., Landar, A., and Song, W. (1995) Brain Res. Bull. 37, 417–429[CrossRef][Medline] [Order article via Infotrieve]
  3. Heizmann, C. W., Fritz, G., and Schafer, B. W. (2002) Front Biosci. 7, 1356–1368[CrossRef]
  4. Marenholz, I., Heizman, C. W., and Fritz, G. (2004) Biochem. Biophys. Res. Commun. 322, 1111–1122[CrossRef][Medline] [Order article via Infotrieve]
  5. Moore, B. (1965) Biochem. Biophys. Res. Commun. 19, 739–744[CrossRef][Medline] [Order article via Infotrieve]
  6. Dukhanina, E. A., Dukhanin, A. S., Lomonosov, M. Y., Lukanidin, E. M., and Georgiev, G. P. (1997) FEBS Lett. 410, 403–406[CrossRef][Medline] [Order article via Infotrieve]
  7. Vallely, K. M., Rustandi, R.R., Ellis, K. C., Varlamova, O., Bresnick, A. R., and Weber, D. J. (2002) Biochemistry 41, 12670–12680[CrossRef][Medline] [Order article via Infotrieve]
  8. Strynadka, N. C., and James, M. N. (1989) Annu. Rev. Biochem. 58, 951–998[CrossRef][Medline] [Order article via Infotrieve]
  9. Weber, D. J., Rustandi, R. R., and Zimmer, D. (2000) in Calcium: the Molecular Basis of Calcium Action in Biology and Medicine (Pochet, R., ed) pp. 469–487, Kluwer Academic Publishers, Netherlands
  10. Dutta, K., Cox, C. J., Huang, H., Basavappa, R., and Pascal, S. M. (2002) Biochemistry 41, 4239–4245[CrossRef][Medline] [Order article via Infotrieve]
  11. Maler, L., Potts, B. C., and Chazin, W. J. (1999) J. Biomol. NMR 13, 233–247[CrossRef][Medline] [Order article via Infotrieve]
  12. Drohat, A. C., Tjandra, N., Baldisseri, D. M., and Weber, D. J. (1999) Protein Sci. 8, 800–809[Medline] [Order article via Infotrieve]
  13. Rustandi, R. R., Baldisseri, D. M., Inman, K. G., Nizner, P., Hamilton, S. M., Landar, A., Landar, A., Zimmer, D. B., and Weber, D. J. (2002) Biochemistry 41, 788–796[CrossRef][Medline] [Order article via Infotrieve]
  14. Kligman, D., and Hilt, D. (1988) Trends Biochem. Sci. 13, 437–443[CrossRef][Medline] [Order article via Infotrieve]
  15. Bhattacharya, S., Large, E., Heizmann, C. W., Hemmings, B., and Chazin, W. J. (2003) Biochemistry 42, 14416–14426[CrossRef][Medline] [Order article via Infotrieve]
  16. Smith, S. P., and Shaw, G. S. (1998) Biochem. Cell Biol. 76, 324–333[CrossRef][Medline] [Order article via Infotrieve]
  17. Inman, K. G., Yang, R., Rustandi, R. R., Miller, K. E., Baldisseri, D. M., and Weber, D. J.(2002) J. Mol. Biol. 324, 1003–1014[CrossRef][Medline] [Order article via Infotrieve]
  18. Rustandi, R. R., Baldisseri, D. M., and Weber, D. J. (2000) Nat. Struct. Biol. 7, 570–574[CrossRef][Medline] [Order article via Infotrieve]
  19. Markowitz, J., Rustandi, R. R., Varney, K. M., Wilder, P. T., Udan, R., Wu, S. L., Horrocks, W. D., and Weber, D. J. (2005) Biochemistry 44, 7305–7314[CrossRef][Medline] [Order article via Infotrieve]
  20. Ebralidze, A., Tulchinsky, E., Grigorian, M., Afanasyeva, A., Senin, V., Revazova, E., and Lukanidin, E. (1989) Genes Dev. 3, 1086–1093[Abstract/Free Full Text]
  21. Strutz, F., Okada, H., Lo, C. W., Danoff, T., Carone, R. L., Tomaszewski, J. E., and Neilson, E. G. (1995) J. Cell Biol. 130, 393–405[Abstract/Free Full Text]
  22. Jackson-Grusby, L. L., Swiergiel, J., and Linzer, D. I. (1987) Nucleic Acids Res. 15, 6677–6690[Abstract/Free Full Text]
  23. Goto, K., Endo, H., and Fujiyoshi, T. (1988) J. Biochem. (Tokyo) 103, 48–53[Abstract/Free Full Text]
  24. Barraclough, R., Savin, J., Dube, S. K., and Rudland, P. S. (1987) J. Mol. Biol. 198, 13–20[CrossRef][Medline] [Order article via Infotrieve]
  25. Masiakowski, P., and Shooter, E. M. (1988) Proc. Natl. Acad. Sci. U. 85, 1277–1281[Abstract/Free Full Text]
  26. Engelkamp, D., Schafer, B. W., Erne, P., and Heizmann, C. W. (1992) Biochemistry 31, 10258–10264[CrossRef][Medline] [Order article via Infotrieve]
  27. Watanabe, Y., Kobayashi, R., Ishikawa, T., and Hidaka, H. (1992) Arch. Biochem. Biophys 292, 563–569[CrossRef][Medline] [Order article via Infotrieve]
  28. Linzer, D. I., and Nathans, D. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 4271–4275[Abstract/Free Full Text]
  29. De Vouge, M. W., and Mukherjee, B. B. (1992) Oncogene 7, 109–119[Medline] [Order article via Infotrieve]
  30. Takenaga, K., Nakamura, Y., Endo, H., and Sakiyama, S. (1994) Jpn. J. Cancer Res. 85, 831–839[CrossRef]
  31. Grigorian, M. S., Tulchinsky, E. M., Zain, S., Ebralidze, A. K., Kramerov, D. A., Kriajevska, M. V., Georgiev, G. P., and Lukanidin, E. M. (1993) Gene (Amst.) 135, 229–238[CrossRef][Medline] [Order article via Infotrieve]
  32. Takenaga, K., Nakamura, Y., and Sakiyama, S. (1994) Cell Struct. Funct. 19, 133–141[Medline] [Order article via Infotrieve]
  33. Gibbs, F. E., Barraclough, R., Platt-Higgins, A., Rudland, P. S., Wilkinson, M. C., and Parry, E. W. (1995) J. Histochem. Cytochem. 43, 169–180[Abstract]
  34. Klingelhofer, J., Ambartsumian, N. S., and Lukanidin, E. M. (1997) Dev. Dyn. 210, 87–95[CrossRef][Medline] [Order article via Infotrieve]
  35. Pedersen, K. B., Nesland, J. M., Fodstad, O., and Maelandsmo, G. M. (2002) Br. J. Cancer 87, 1281–1286[CrossRef][Medline] [Order article via Infotrieve]
  36. Rosty, C., Ueki, T., Argani, P., Jansen, M., Yeo, C. J., Cameron, J. L., Hruban, R. H., and Goggins, M. (2002) Am. J. Pathol. 160, 45–50[Abstract/Free Full Text]
  37. Gupta, S., Hussain, T., MacLennan, G. T., Fu, P., Patel, J., and Mukhtar, H. (2003) J. Clin. Oncol. 21, 106–112[Abstract/Free Full Text]
  38. Nakamura, T., Ajiki, T., Murao, S., Kamigaki, T., Maeda, S., Ku, Y., and Kuroda, Y. (2002) Int. J. Oncol. 20, 937–941[Medline] [Order article via Infotrieve]
  39. Ninomiya, I., Ohta, T., Fushida, S., Endo, Y., Hashimoto, T., Yagi, M., Fujimura, T., Nishimura, G., Tani, T., Shimizu, K., Yonemura, Y., Heizmann, C. W., Schafer, B. W., Sasaki, T., and Miwa, K. (2001) Int. J. Oncol. 18, 715–720[Medline] [Order article via Infotrieve]
  40. Yonemura, Y., Endou, Y., Kimura, K., Fushida, S., Bandou, E., Taniguchi, K., Kinoshita, K., Ninomiya, I., Sugiyama, K., Heizmann, C. W., Schafer, B. W., and Sasaki, T. (2000) Clin. Cancer Res. 6, 4234–4242[Abstract/Free Full Text]
  41. Kimura, K., Endo, Y., Yonemura, Y., 16, Heizmann, C. W., Schafer, B. W., Watanabe, Y., and Sasaki, T. (2000) Int. J. Oncol. 16 1125–1131[Medline] [Order article via Infotrieve]
  42. Ito, Y., Yoshida, H., Tomoda, C., Uruno, T., Miya, A., Kobayashi, K., Matsuzuka, F., Kakudo, K., Kuma, K., and Miyauchi, A. (2004) Oncology 67, 397–402[CrossRef][Medline] [Order article via Infotrieve]
  43. Davies, B.R., Davies, M. P., Gibbs, F. E., Barraclough, R., and Rudland, P. S. (1993) Oncogene 8, 999–1008[Medline] [Order article via Infotrieve]
  44. Grigorian, M., Ambartsumian, N., Lykkesfeldt, A. E., Bastholm, L., Elling, F., Georgiev, G., and Lukanidin, E. (1996) Int. J. Cancer 67, 831–841[CrossRef][Medline] [Order article via Infotrieve]
  45. Ambartsumian, N. S., Grigorian, M. S., Larsen, I. F., Karlstrom, O., Sidenius, N., Rygaard, J., Georgiev, G., and Lukanidin, E. (1996) Oncogene 13, 1621–1630[Medline] [Order article via Infotrieve]
  46. Davies, M. P., Rudland, P. S., Robertson, L., Parry, E. W., Jolicoeur, P., and Barraclough, R. (1996) Oncogene 13, 1631–1637[Medline] [Order article via Infotrieve]
  47. Maelandsmo, G. M., Hovig, E., Skrede, M., Engebraaten, O., Florenes, V. A., Myklebost, O., Grigorian, M., Lukanidin, E., Scanlon, K. J., and Fodstad, O. (1996) Cancer Res. 56, 5490–5498[Abstract/Free Full Text]
  48. Takenaga, K., Nakamura, Y., and Sakiyama, S. (1997) Oncogene 14, 331–337[CrossRef][Medline] [Order article via Infotrieve]
  49. Xue, C., Plieth, D., Venkov, C., Xu, C., and Neilson, E. G. (2003) Cancer Res. 63, 3386–3394[Abstract/Free Full Text]
  50. Platt-Higgins, A. M., Renshaw, C. A., West, C. R., Winstanley, J. H., De Silva Rudland, S., Barraclough, R., and Rudland, P. S. (2000) Int. J. Cancer 89, 198–208[CrossRef][Medline] [Order article via Infotrieve]
  51. Rudland, P. S., Platt-Higgins, A., Renshaw, C., West, C. R., Winstanley, J. H., Robertson, L., and Barraclough, R. (2000) Cancer Res. 60, 1595–1603[Abstract/Free Full Text]
  52. Andersen, K., Nesland, J. M., Holm, R., Florenes, V. A., Fodstad, O., and Maelandsmo, G. M. (2004) Mod. Pathol. 17, 990–997[CrossRef][Medline] [Order article via Infotrieve]
  53. Saleem, M., Adhami, V. M., Ahmad, N., Gupta, S., and Mukhtar, H. (2005) Clin. Cancer Res. 11, 147–153[Abstract/Free Full Text]
  54. Davies, B. R., O'Donnell, M., Durkan, G. C., Rudland, P. S., Barraclough, R., Neal, D. E., and Mellon, J. K. (2002) J. Pathol. 196, 292–299[CrossRef][Medline] [Order article via Infotrieve]
  55. Iacobuzio-Donahue, C. A., Ashfaq, R., Maitra, A., Adsay, N. V., Shen-Ong, G. L., Berg, K., Hollingsworth, M. A., Cameron, J. L., Yeo, C. J., Kern, S. E., Goggins, M., and Hruban, R. H. (2003) Cancer Res. 63, 8614–8622[Abstract/Free Full Text]
  56. Ravasi, T., Hsu, K., Goyette, J., Schroder, K., Yang, Z., Rahimi, F., Miranda, L. P., Alewood, P. F., Hume, D. A., and Geczy, C. (2004) Genomics 84, 10–22[CrossRef][Medline] [Order article via Infotrieve]
  57. Lukanidin, E. M., and Georgiev, G. P. (1996) Curr. Top Microbiol. Immunol. 213, 171–195[Medline] [Order article via Infotrieve]
  58. Ambartsumian, N., Tarabykina, S., Grigorian, M., Tulchinsky, E., Hulgaard, E., Georgiev, G., and Lukanidin, E. (1995) Gene (Amst.) 159, 125–130[CrossRef][Medline] [Order article via Infotrieve]
  59. Hernan, R., Fasheh, R., Calabrese, C., Frank, A. J., Maclean, K. H., Allard, D., Barraclough, R., and Gilbertson, R. J. (2003) Cancer Res. 63, 140–148[Abstract/Free Full Text]
  60. Tulchinsky, E., Kramerov, D., Ford, H. L., Reshetnyak, E., Lukanidin, E., and Zain, S. (1993) Oncogene 8, 79–86[Medline] [Order article via Infotrieve]
  61. Tulchinsky, E. M., Georgiev, G. P., and Lukanidin, E. M. (1996) Oncogene 12, 1737–1745[Medline] [Order article via Infotrieve]
  62. Tulchinsky, E., Prokhortchouk, E., Georgiev, G., and Lukanidin, E. (1997) J. Biol. Chem. 272, 4828–4835[Abstract/Free Full Text]
  63. Cohn, M. A., Hjelmso, I., Wu, L. C., Guldberg, P., Lukanidin, E. M., and Tulchinsky, E. M. (2001) Nucleic Acids Research 29, 3335–3346[Abstract/Free Full Text]
  64. Tulchinsky, E., Ford, H. L., Kramerov, D., Reshetnyak, E., Grigorian, M., Zain, S., and Lukanidin, E. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9146–9150[Abstract/Free Full Text]
  65. Chen, D., Rudland, P. S., Chen, H. L., and Barraclough, R. (1999) J. Biol. Chem. 274, 2483–2491[Abstract/Free Full Text]
  66. Tulchinsky, E., Grigorian, M., Tkatch, T., Georgiev, G., and Lukanidin, E. (1995) Biochim. Biophys. Acta 1261, 243–248[Medline] [Order article via Infotrieve]
  67. El Naaman, C., Grum-Schwensen, B., Mansouri, A., Grigorian, M., Santoni-Rugiu, E., Hansen, T., Kriajevska, M., Schafer, B. W., Heizmann, C. W., Lukanidin, E., and Ambartsumian, N. (2004) Oncogene 23, 3670–3680[CrossRef][Medline] [Order article via Infotrieve]
  68. Grum-Schwensen, B., Klingelhofer, J., Berg, C. H., El-Naaman, C., Grigorian, M., Lukanidin, E., and Ambartsumian, N. (2005) Cancer Res. 65, 3772–3780[Abstract/Free Full Text]
  69. Kriajevska, M., Fischer-Larsen, M., Moertz, E., Vorm, O., Tulchinsky, E., Grigorian, M., Ambartsumian, N., and Lukanidin, E. (2002) J. Biol. Chem. 277, 5229–5235[Abstract/Free Full Text]
  70. Endo, H., Takenaga, K., Kanno, T., Satoh, H., and Mori, S. (2002) J. Biol. Chem. 277, 26396–26402[Abstract/Free Full Text]
  71. Grigorian, M., Andresen, S., Tulchinsky, E., Kriajevska, M., Carlberg, C., Kruse, C., Cohn, M., Ambartsumian, N., Christensen, A., Selivanova, G., and Lukanidin, E. (2001) J. Biol. Chem. 276, 22699–22708[Abstract/Free Full Text]
  72. Takenaga, K., Nakamura, Y., Sakiyama, S., Hasegawa, Y., Sato, K., and Endo, H. (1994) J. Cell Biol. 124, 757–768[Abstract/Free Full Text]
  73. Watanabe, Y., Usada, N., Minami, H., Morita, T., Tsugane, S., Ishikawa, R., Kohama, K., Tomida, Y., and Hidaka, H. (1993) FEBS Lett. 324, 51–55[CrossRef][Medline] [Order article via Infotrieve]
  74. Kriajevska, M. V., Cardenas, M. N., Grigorian, M. S., Ambartsumian, N. S., Georgiev, G. P., and Lukanidin, E. M. (1994) J. Biol. Chem. 269, 19679–19682[Abstract/Free Full Text]
  75. Tarabykina, S., Kriajevska, M., Scott, D. J., Hill, T. J., Lafitte, D., Derrick, P. J., Dodson, G. G., Lukanidin, E., and Bronstein, I. (2000) FEBS Lett. 475, 187–191[CrossRef][Medline] [Order article via Infotrieve]
  76. Wang, G., Rudland, P. S., White, M. R., and Barraclough, R. (2000) J. Biol. Chem. 275, 11141–11146[Abstract/Free Full Text]
  77. Yang, Q., O'Hanlon, D., Heizmann, C. W., and Marks, A. (1999) Exp. Cell Res. 246, 501–509[CrossRef][Medline] [Order article via Infotrieve]
  78. Deloulme, J. C., Assard, N., Mbele, G. O., Mangin, C., Kuwano, R., and Baudier, J. (2000) J. Biol. Chem. 275, 35302–35310[Abstract/Free Full Text]
  79. Drohat, A. C., Nenortas, E., Beckett, D., and Weber, D. J. (1997) Protein Sci. 6, 1577–1582[Medline] [Order article via Infotrieve]
  80. Baudier, J., Delphin, C., Grunwald, D., Khochbin, S., and Lawrence, J. J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 11627–11631[Abstract/Free Full Text]
  81. Delphin, C., Ronjat, M., Deloulme, J. C., Garin, G., Debussche, L., Higashimoto, Y., Sakaguchi, K., and Baudier, J. (1999) J. Biol. Chem. 274, 10539–10544[Abstract/Free Full Text]
  82. Lin, J., Blake, M., Tang, C., Zimmer, D., Rustandi, R. R., Weber, D. J., and Carrier, F. (2001) J. Biol. Chem. 276, 35037–35041[Abstract/Free Full Text]
  83. Ford, H. L., Silver, D. L., Kachar, B., Sellers, J. R., and Zain, S. B. (1997) Biochemistry 36, 16321–16327[CrossRef][Medline] [Order article via Infotrieve]
  84. Li, Z. H., Spektor, A., Varlamova, O., and Bresnick, A. R. (2003) Biochemistry 42, 14258–14266[CrossRef][Medline] [Order article via Infotrieve]
  85. Kriajevska, M., Tarabykina, S., Bronstein, I., Maitland, N., Lomonosov, M., Hansen, K., Georgiev, G., and Lukanidin, E. (1998) J. Biol. Chem. 273, 9852–9856[Abstract/Free Full Text]
  86. Dulyaninova, N. G., Malashkevich, V. N., Almo, S. C., and Bresnick, A. R. (2005) Biochemistry 44, 6867–6876[CrossRef][Medline] [Order article via Infotrieve]
  87. Schmidt-Hansen, B., Klingelhofer, J., Grum-Schwensen, B., Christensen, A., Andresen, S., Kruse, C., Hansen, T., Ambartsumian, N., Lukanidin, E., and Grigorian, M. (2004) J. Biol. Chem. 279, 24498–24504[Abstract/Free Full Text]
  88. Ambartsumian, N., Klingelhofer, J., Grigorian, M., Christensen, C., Kriajevska, M., Tulchinsky, E., Georgiev, G., Berezin, V., Bock, E., Rygaard, J., Cao, R., Cao, Y., and Lukanidin, E. (2001) Oncogene 20, 4685–4695[CrossRef][Medline] [Order article via Infotrieve]
  89. Bjornland, K., Winberg, J. O., Odegaard, O. T., Hovig, E., Loennechen, T., Aasen, A. O., Fodstad, O., and Maelandsmo, G. M. (1999) Cancer Res. 59, 4702–4708[Abstract/Free Full Text]
  90. Miyamori, H., Hasegawa, K., Kim, K. R., and Sato, H. (2000) Clin. Exp. Metastasis 18, 51–56[CrossRef][Medline] [Order article via Infotrieve]
  91. Semov, A., Moreno, M. J., Onichtchenko, A., Abulrob, A., Ball, M., Ekiel, I., Pietrzynski, G., Stanimirovic, D., and Alakhov, V. (2005) J. Biol. Chem. 280, 20833–20841[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
J. Cedervall, S. Jamil, L. Prasmickaite, Y. Cheng, M. Eskandarpour, J. Hansson, G. M. Maelandsmo, U. Ringborg, M. Gulyas, H. S. Zhen, et al.
Species-Specific In vivo Engraftment of the Human BL Melanoma Cell Line Results in an Invasive Dedifferentiated Phenotype Not Present in Xenografts
Cancer Res., May 1, 2009; 69(9): 3746 - 3754.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Yan, C. Zhou, X. Lou, Z. Xiao, H. Zhu, Q. Wang, Y. Wang, N. Lu, S. He, Q. Zhan, et al.
PTTG Overexpression Promotes Lymph Node Metastasis in Human Esophageal Squamous Cell Carcinoma
Cancer Res., April 15, 2009; 69(8): 3283 - 3290.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Chen, M. Sinha, B. A. Luxon, A. R. Bresnick, and K. L. O'Connor
Integrin {alpha}6{beta}4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin
J. Biol. Chem., January 16, 2009; 284(3): 1484 - 1494.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. S. Gridley, J. M. Slater, X. Luo-Owen, A. Rizvi, S. K. Chapes, L. S. Stodieck, V. L. Ferguson, and M. J. Pecaut
Spaceflight effects on T lymphocyte distribution, function and gene expression
J Appl Physiol, January 1, 2009; 106(1): 194 - 202.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Bulk, B. Sargin, U. Krug, A. Hascher, Y. Jun, M. Knop, C. Kerkhoff, V. Gerke, R. Liersch, R. M. Mesters, et al.
S100A2 Induces Metastasis in Non-Small Cell Lung Cancer
Clin. Cancer Res., January 1, 2009; 15(1): 22 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. A. Harris, H. Yang, B. E. Low, J. Mukherje, A. Guha, R. T. Bronson, L. D. Shultz, M. A. Israel, and K. Yun
Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
Cancer Res., December 15, 2008; 68(24): 10051 - 10059.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Austermann, A. R. Nazmi, C. Muller-Tidow, and V. Gerke
Characterization of the Ca2+-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration
J. Biol. Chem., October 24, 2008; 283(43): 29331 - 29340.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Ganesan, T. Ivanova, Y. Wu, V. Rajasegaran, J. Wu, M. H. Lee, K. Yu, S. Y. Rha, H. C. Chung, B. Ylstra, et al.
Inhibition of Gastric Cancer Invasion and Metastasis by PLA2G2A, a Novel {beta}-Catenin/TCF Target Gene
Cancer Res., June 1, 2008; 68(11): 4277 - 4286.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
L. M. Orre, M. Pernemalm, J. Lengqvist, R. Lewensohn, and J. Lehtio
Up-regulation, Modification, and Translocation of S100A6 Induced by Exposure to Ionizing Radiation Revealed by Proteomics Profiling
Mol. Cell. Proteomics, December 1, 2007; 6(12): 2122 - 2131.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
N. G. Dulyaninova, R. P. House, V. Betapudi, and A. R. Bresnick
Myosin-IIA Heavy-Chain Phosphorylation Regulates the Motility of MDA-MB-231 Carcinoma Cells
Mol. Biol. Cell, August 1, 2007; 18(8): 3144 - 3155.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Schneider, S. Kostin, C. C. Strom, M. Aplin, S. Lyngbaek, J. Theilade, M. Grigorian, C. B. Andersen, E. Lukanidin, J. Lerche Hansen, et al.
S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes
Cardiovasc Res, July 1, 2007; 75(1): 40 - 50.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. J. Rivard, L. M. Brown, N. E. Almeida, A. B. Maunsbach, K. Pihakaski-Maunsbach, A. Andres-Hernando, J. M. Capasso, and T. Berl
Expression of the Calcium-binding Protein S100A4 Is Markedly Up-regulated by Osmotic Stress and Is Involved in the Renal Osmoadaptive Response
J. Biol. Chem., March 2, 2007; 282(9): 6644 - 6652.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Saleem, M.-H. Kweon, J. J. Johnson, V. M. Adhami, I. Elcheva, N. Khan, B. Bin Hafeez, K. M. R. Bhat, S. Sarfaraz, S. Reagan-Shaw, et al.
S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9
PNAS, October 3, 2006; 103(40): 14825 - 14830.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. C.J. Polley, F. Mulholland, C. Pin, E. A. Williams, D. M. Bradburn, S. J. Mills, J. C. Mathers, and I. T. Johnson
Proteomic Analysis Reveals Field-Wide Changes in Protein Expression in the Morphologically Normal Mucosa of Patients with Colorectal Neoplasia.
Cancer Res., July 1, 2006; 66(13): 6553 - 6562.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Betapudi, L. S. Licate, and T. T. Egelhoff
Distinct Roles of Nonmuscle Myosin II Isoforms in the Regulation of MDA-MB-231 Breast Cancer Cell Spreading and Migration.
Cancer Res., May 1, 2006; 66(9): 4725 - 4733.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
X. Luo, L. Ding, and N. Chegini
CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-{beta} and regulation by TGF-{beta} in leiomyoma and myometrial smooth muscle cells
Mol. Hum. Reprod., April 1, 2006; 12(4): 245 - 256.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/2/677    most recent
R500017200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garrett, S. C.
Right arrow Articles by Bresnick, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garrett, S. C.
Right arrow Articles by Bresnick, A. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement